vaccine_ndc,dosage_text
49281-860,"Dosage Form: INJECTION, SUSPENSION. POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED): 40 [D'ag'U]/.5mL. POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [D'ag'U]/.5mL. POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED): 32 [D'ag'U]/.5mL"
49281-912,Dosage Form: INJECTION. SODIUM CHLORIDE: 4.5 mg/.5mL
0069-2432,"Dosage Form: INJECTION, SUSPENSION. BNT162B2 OMICRON (KP.2): .042 mg/.418mL"
0006-4329,"Dosage Form: INJECTION, SUSPENSION. CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN: 30 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL..."
49281-913,Dosage Form: KIT
14362-0111,Dosage Form: INJECTION. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL
68263-001,"Dosage Form: INJECTION, SUSPENSION. CX-038839 OMICRON (XBB.1.5): 50 ug/.5mL"
84586-001,"Dosage Form: INJECTION, SUSPENSION. CX-038839 OMICRON (XBB.1.5): 50 ug/.5mL"
68594-027,Dosage Form: SUSPENSION. NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN: .06 mg/.06mg
68594-028,Dosage Form: SUSPENSION. NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN: .06 mg/.06mg
50090-2062,"Dosage Form: INJECTION, SUSPENSION. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL"
58160-726,Dosage Form: KIT
69806-0001,Dosage Form: LIQUID. HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN: 1 g/g
58160-740,Dosage Form: SOLUTION. HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN: 1000 [CCID_50]/mL
69806-0002,Dosage Form: LIQUID. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 1 g/g
58160-757,Dosage Form: KIT
58160-810,"Dosage Form: SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 25 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 25 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 10 [iU]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL"
0005-1971,"Dosage Form: INJECTION, SUSPENSION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR..."
0006-4681,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN: 1000 [TCID_50]/.5mL. MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN: 12500 [TCID_50]/.5mL. RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN: 1000 [TCID_50]/.5mL"
58160-811,"Dosage Form: INJECTION, SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 25 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 25 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 10 [iU]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL. HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN: 10 ug/.5mL. POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED): 40 [iU]/.5mL. POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [iU]/.5mL. POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED): 32 [iU]/.5mL"
58160-812,"Dosage Form: INJECTION, SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 25 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 10 [iU]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL. POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED): 40 [iU]/.5mL. POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [iU]/.5mL. POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED): 32 [iU]/.5mL"
58160-815,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED): 720 [iU]/mL. HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/mL"
66019-311,Dosage Form: SPRAY. INFLUENZA A VIRUS A/NORWAY/31694/2022 (H1N1) LIVE (ATTENUATED) ANTIGEN: 10000000 [FFU]/.2mL. INFLUENZA A VIRUS A/THAILAND/8/2022 (H3N2) LIVE: 10000000 [FFU]/.2mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 LIVE (ATTENUATED) ANTIGEN: 10000000 [FFU]/.2mL
58160-818,Dosage Form: KIT
49281-124,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.5mL"
58160-819,Dosage Form: KIT
58160-820,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN: 10 ug/.5mL"
49281-215,"Dosage Form: INJECTION, SUSPENSION. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL"
58160-821,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/mL"
49281-224,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL"
58160-823,Dosage Form: KIT
49281-225,"Dosage Form: INJECTION, SUSPENSION. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [Lf]/.5mL"
58160-824,Dosage Form: KIT
0006-4981,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 5 ug/.5mL"
58160-825,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED): 720 [iU]/.5mL"
49281-252,Dosage Form: KIT
58160-826,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED): 1440 [iU]/mL"
0069-0411,Dosage Form: INJECTION. TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED): 2.4 ug/.5mL
49281-286,"Dosage Form: INJECTION, SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 5 ug/.5mL. BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN: 5 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN: 3 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED): 10 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 15 [Lf]/.5mL"
58160-827,"Dosage Form: INJECTION, SOLUTION. NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 5 ug/.5mL. NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 5 ug/.5mL. NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 5 ug/.5mL"
49281-400,"Dosage Form: INJECTION, SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 5 ug/.5mL. BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN: 5 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN: 3 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED): 2.5 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL"
58160-842,"Dosage Form: SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 8 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [iU]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 [iU]/.5mL"
49281-424,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL"
58160-848,Dosage Form: KIT
49281-511,Dosage Form: KIT
49281-539,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL"
58160-855,"Dosage Form: INJECTION, SOLUTION"
49281-545,Dosage Form: KIT
58160-884,Dosage Form: SUSPENSION. INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL
49281-564,"Dosage Form: INJECTION, SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 20 ug/.5mL. BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN: 5 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN: 3 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED): 20 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 15 [Lf]/.5mL. POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED): 29 [D'ag'U]/.5mL. POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED): 7 [D'ag'U]/.5mL. POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED): 26 [D'ag'U]/.5mL"
58160-955,Dosage Form: KIT
58160-976,"Dosage Form: INJECTION, SUSPENSION. NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN: 50 ug/.5mL. NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN: 50 ug/.5mL. NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN: 50 ug/.5mL. NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN: 25 ug/.5mL"
49281-589,"Dosage Form: INJECTION, SOLUTION. NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN: 4 ug/.5mL. NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN: 4 ug/.5mL. NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN: 4 ug/.5mL. NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN: 4 ug/.5mL"
0006-4109,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL"
49281-590,"Dosage Form: INJECTION, SOLUTION. NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL"
49281-605,Dosage Form: KIT
49281-641,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL"
49281-722,Dosage Form: INJECTION. INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL. INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL
49281-724,Dosage Form: INJECTION. INFLUENZA A VIRUS A/MASSACHUSETTS/18/2022 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL. INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN: 45 ug/.5mL
49281-790,"Dosage Form: INJECTION, SOLUTION. SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN: 25 ug/.5mL"
0006-4897,"Dosage Form: INJECTION, SUSPENSION. HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN: 7.5 ug/.5mL"
50024-100,"Dosage Form: INJECTION, SUSPENSION. CX-038839 OMICRON (XBB.1.5): 50 ug/.5mL"
69497-0090,"Dosage Form: INJECTION, SOLUTION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMON..."
69497-0101,"Dosage Form: INJECTION, SOLUTION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMON..."
69497-0102,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL"
69497-0103,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL"
69497-0134,"Dosage Form: INJECTION, SUSPENSION. CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN: 30 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL..."
50090-3372,Dosage Form: KIT
69497-0141,"Dosage Form: INJECTION, SOLUTION. CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN: 65 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 16F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/...."
50632-001,"Dosage Form: INJECTION, SUSPENSION. VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN: 50000000 1/.5mL"
0006-4095,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL"
50090-1223,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/mL"
50632-010,Dosage Form: KIT
50632-015,Dosage Form: KIT
50632-016,"Dosage Form: CAPSULE, COATED. SALMONELLA TYPHI TY21A LIVE ANTIGEN: 6000000000 [CFU]/1"
50632-018,"Dosage Form: INJECTION, SUSPENSION. CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 CAPSID PROTEIN: 10 ug/.8mL. CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E1: 15 ug/.8mL. CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E2: 15 ug/.8mL"
50632-022,"Dosage Form: INJECTION, SUSPENSION. VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN: 50000000 1/.5mL"
50632-023,"Dosage Form: INJECTION, SUSPENSION. VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN: 50000000 1/.5mL"
0052-0603,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN: 50 mg/1"
0006-4293,"Dosage Form: INJECTION, SOLUTION. ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN: 72000000 [PFU]/mL"
51285-138,Dosage Form: KIT
0006-4837,"Dosage Form: INJECTION, SOLUTION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMON..."
0069-0344,Dosage Form: KIT
50090-1377,"Dosage Form: SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 8 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [iU]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 [iU]/.5mL"
0006-4093,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 5 ug/.5mL"
19515-810,"Dosage Form: SUSPENSION. INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 ANTIGEN (UV, FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED): 15 ug/.5mL"
50090-6026,"Dosage Form: INJECTION, SUSPENSION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CA..."
0006-4171,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN: 1000 [TCID_50]/.5mL. MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN: 20000 [TCID_50]/.5mL. RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN: 1000 [TCID_50]/.5mL. VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN: 9772 [PFU]/.5mL"
0005-2000,"Dosage Form: INJECTION, SUSPENSION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CA..."
0006-4827,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN: 1350 [PFU]/.5mL"
50090-1493,"Dosage Form: INJECTION, SOLUTION. SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN: 25 ug/.5mL"
50090-7036,"Dosage Form: INJECTION, SOLUTION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMON..."
64678-211,"Dosage Form: INJECTION, SUSPENSION. BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS: 100 ug/mL"
50090-1502,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED): 1440 [iU]/mL"
0006-4992,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 40 ug/mL"
0006-4045,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL"
70460-004,Dosage Form: KIT
33332-024,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL"
50090-3781,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED): 720 [iU]/.5mL"
70461-024,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL"
70461-554,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/SYDNEY/1304/2022 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL"
33332-124,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL"
42515-002,"Dosage Form: INJECTION, SUSPENSION. JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED): 6 [arb'U]/.5mL"
70461-654,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/SYDNEY/1304/2022 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL"
42515-003,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. CHIKUNGUNYA VIRUS LR2006 OPY1 (ATTENUATED STRAIN) ANTIGEN: 3 [TCID_50]/.5mL"
0006-4119,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL"
63361-243,"Dosage Form: INJECTION, SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 20 ug/.5mL. BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN: 5 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN: 3 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED): 20 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 15 [Lf]/.5mL. HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN: 3 ug/.5mL. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 10 ug/.5mL. POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED): 29 [D'ag'U]/.5mL. POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED): 7 [D'ag'U]/.5mL. POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED): 26 [D'ag'U]/.5mL"
65044-2161,"Dosage Form: INJECTION, SUSPENSION. BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS: 100 ug/mL"
69401-000,"Dosage Form: CAPSULE, COATED. SALMONELLA TYPHI TY21A LIVE ANTIGEN: 6000000000 [CFU]/1"
49281-915,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN: 4.74 [PFU]/.5mL"
49281-924,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL"
49281-935,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED): 60 ug/.7mL"
0069-0600,Dosage Form: KIT
0005-0100,"Dosage Form: INJECTION, SUSPENSION. NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN: 60 ug/.5mL. NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN: 60 ug/.5mL"
75052-001,"Dosage Form: INJECTION, SUSPENSION. RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM L): .6 ug/mL. RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM M): 1.1 ug/mL. RECOMBINANT HEPATITIS B SURFACE ANTIGEN (ISOFORM S): 10 ug/mL"
83703-044,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 ug/.5mL"
0069-2465,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN: .06 mg/.5mL. RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN: .06 mg/.5mL"
83703-045,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL"
0006-4347,"Dosage Form: INJECTION, SOLUTION. CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN: 65 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 16F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 4 ug/...."
83703-046,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED): 50 [iU]/mL"
50090-1860,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN: 1000 [TCID_50]/.5mL. MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN: 12500 [TCID_50]/.5mL. RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN: 1000 [TCID_50]/.5mL"
83703-047,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL"
83703-048,"Dosage Form: INJECTION, SOLUTION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/.5mL"
50090-1645,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED): 720 [iU]/mL. HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/mL"
83703-049,"Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION. MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN: 1000 [TCID_50]/.5mL. MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN: 12500 [TCID_50]/.5mL. RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN: 1000 [TCID_50]/.5mL"
83703-061,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/CALIFORNIA/122/2022 SAN-022 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL. INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL. INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED): 15 mg/.5mL"
83703-062,"Dosage Form: INJECTION, SUSPENSION. INFLUENZA A VIRUS A/GEORGIA/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/SYDNEY/1304/2022 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/SINGAPORE/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED): 15 ug/.5mL"
50090-4958,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL"
0006-4943,"Dosage Form: INJECTION, SOLUTION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 15B CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 17F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 2 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 20 CAPSULAR POLYSACCHARIDE ANTIGEN: 25 ug/.5mL. STREPTOCOCCUS PNEUMON..."
80777-110,"Dosage Form: INJECTION, SUSPENSION. CX-046684: 50 ug/.5mL"
80777-291,"Dosage Form: INJECTION, SUSPENSION. CX-046684: 25 ug/.25mL"
80777-345,Dosage Form: SUSPENSION. RNA-100-AR02: 50 ug/.5mL
68225-228,"Dosage Form: INJECTION, SUSPENSION. CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN: 30 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 22F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2 ug/.5mL..."
50090-1693,"Dosage Form: INJECTION, SUSPENSION. POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED): 40 [D'ag'U]/.5mL. POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED): 8 [D'ag'U]/.5mL. POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED): 32 [D'ag'U]/.5mL"
0006-4096,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED): 50 [iU]/mL"
0006-4309,Dosage Form: INJECTION. WATER: .7 mL/.7mL
59267-4426,"Dosage Form: INJECTION, SUSPENSION. BNT162B2 OMICRON (KP.2): .0158 mg/1.58mL"
71665-001,"Dosage Form: INJECTION, SUSPENSION. BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS: 100 ug/mL"
59267-4438,"Dosage Form: INJECTION, SUSPENSION. BNT162B2 OMICRON (KP.2): .0158 mg/.48mL"
0006-4841,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED): 50 [iU]/mL"
13533-131,"Dosage Form: INJECTION, SOLUTION. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2 [Lf]/.5mL"
0006-4094,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 10 ug/mL"
50090-1831,"Dosage Form: SUSPENSION. BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED): 8 ug/.5mL. BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 ug/.5mL. BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED): 8 ug/.5mL. CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 5 [iU]/.5mL. CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED): 2.5 [iU]/.5mL"
0069-0297,Dosage Form: INJECTION. TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED): 1.2 ug/.25mL
50090-6180,"Dosage Form: INJECTION, SOLUTION. NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL. NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN: 10 ug/.5mL"
0006-4175,Dosage Form: INJECTION. WATER: .7 mL/.7mL
62195-051,"Dosage Form: INJECTION, SUSPENSION. JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED): 6 ug/.5mL"
63552-192,"Dosage Form: INJECTION, SOLUTION. INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL. INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED): 15 ug/.5mL"
43528-003,"Dosage Form: INJECTION, SOLUTION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/.5mL"
0006-4831,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED): 25 [iU]/.5mL"
80631-107,"Dosage Form: INJECTION, SUSPENSION. NVX-COV2705: 5 ug/.5mL"
0006-4995,"Dosage Form: INJECTION, SUSPENSION. HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 10 ug/mL"
63552-212,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL"
50090-1944,"Dosage Form: INJECTION, SUSPENSION. STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 23F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 3 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 4 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN: 2.2 ug/.5mL. STREPTOCOCCUS PNEUMONIAE TYPE 5 CAPSULAR..."
0006-4047,Dosage Form: SOLUTION. HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN: 2200000 [iU]/2mL. HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN: 2800000 [iU]/2mL. HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN: 2200000 [iU]/2mL. HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN: 2000000 [iU]/2mL. HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN: 2300000 [iU]/2mL
0006-4121,"Dosage Form: INJECTION, SUSPENSION. HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN: 60 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN: 40 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN: 20 ug/.5mL. HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN: 30 ug/.5mL"
